Lyme borreliosis

被引:21
作者
Schnarr, Sebastian
Franz, Juliane K.
Krause, Andreas
Zeidler, Henning [1 ]
机构
[1] Hannover Med Sch, Dept Internal Med, Div Rheumatol, D-3000 Hannover, Germany
[2] Rheumaklin Ostbayern, Bad Fuessing, Germany
[3] Privatklin Pk, Bad Schinznach, Switzerland
[4] Immanuel Hosp, Rheumakliniken Berlin Burch & Berlin Wannsee, Berlin, Germany
来源
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2006年 / 20卷 / 06期
关键词
Lyme disease; Lyme borreliosis; Borrelia burgdorferi; epidemiology; pathogenesis; diagnosis; therapy; prevention; vaccine;
D O I
10.1016/j.berh.2006.08.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lyme borreliosis is a tick-borne infectious disease caused by the spirochaetes Borrelia burgdorferi, B. garinii and B. aftelii. It comprises a wide spectrum of symptoms affecting skin, musculoskeletal system, heart, eyes, central and peripheral nervous system. The diagnosis is based on clinical findings in combination with detection of specific IgM and/or IgG antibodies. Diagnostic problems arise from patients with non-specific symptoms and positive IgG antibody detection. Adequate antibiotic therapy cures more than 90% of the patients. However, in some patients repeated therapy is necessary and a small number of patients develop chronic arthritis or other features. While there is currently no vaccine available, prevention of tick bite is the most effective prophylaxis.
引用
收藏
页码:1099 / 1118
页数:20
相关论文
共 78 条
[71]   Aspects of Lyme borreliosis in Europe [J].
Weber, K .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2001, 20 (01) :6-13
[72]   AZITHROMYCIN VERSUS PENICILLIN V FOR THE TREATMENT OF EARLY LYME BORRELIOSIS [J].
WEBER, K ;
WILSKE, B ;
PREACMURSIC, V ;
THURMAYR, R .
INFECTION, 1993, 21 (06) :367-372
[73]   Gabapentin for the symptomatic treatment of chronic neuropathic pain in patients with late-stage Lyme borreliosis: A pilot study [J].
Weissenbacher, S ;
Ring, J ;
Hofmann, H .
DERMATOLOGY, 2005, 211 (02) :123-127
[74]   Epidemiology and diagnosis of Lyme borreliosis [J].
Wilske, B .
ANNALS OF MEDICINE, 2005, 37 (08) :568-579
[75]   RECOMBINANT IMMUNOBLOT IN THE SERODIAGNOSIS OF LYME BORRELIOSIS - COMPARISON WITH INDIRECT IMMUNOFLUORESCENCE AND ENZYME-LINKED-IMMUNOSORBENT-ASSAY [J].
WILSKE, B ;
FINGERLE, V ;
HERZER, P ;
HOFMANN, A ;
LEHNERT, G ;
PETERS, H ;
PFISTER, HW ;
PREACMURSIC, V ;
SOUTSCHEK, E ;
WEBER, K .
MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1993, 182 (05) :255-270
[76]   Practice guidelines for the treatment of Lyme disease [J].
Wormser, GP ;
Nadelman, RB ;
Dattwyler, RJ ;
Dennis, DT ;
Shapiro, ED ;
Steere, AC ;
Rush, TJ ;
Rahn, DW ;
Coyle, PK ;
Persing, DH ;
Fish, D ;
Luft, BJ .
CLINICAL INFECTIOUS DISEASES, 2000, 31 :S1-S14
[77]   Yield of large-volume blood cultures in patients with early Lyme disease [J].
Wormser, GP ;
Bittker, S ;
Cooper, D ;
Nowakowski, J ;
Nadelman, RB ;
Pavia, C .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (08) :1070-1072
[78]  
Zore A, 2002, WIEN KLIN WOCHENSCHR, V114, P606